Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. Pacific Edge Limited
  6. Summary
    PEB   NZPEBE0002S1

PACIFIC EDGE LIMITED

(PEB)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote New Zealand Stock Exchang…
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
1.22 1.23 1.24 1.23 1.22 Last
733373 9013354 315770 355828 380590 Volume
+0.83% +0.82% +0.81% -0.81% -0.81% Change
Estimated financial data (e)
Sales 2022 21,7 M 15,1 M 15,1 M
Net income 2022 -9,03 M -6,28 M -6,28 M
Net cash position 2022 12,8 M 8,89 M 8,89 M
P/E ratio 2022 -98,3x
Yield 2022 -
Sales 2023 48,3 M 33,6 M 33,6 M
Net income 2023 8,20 M 5,70 M 5,70 M
Net cash position 2023 17,9 M 12,4 M 12,4 M
P/E ratio 2023 108x
Yield 2023 -
Capitalization 889 M 620 M 619 M
EV / Sales 2022 40,5x
EV / Sales 2023 18,0x
Nbr of Employees -
Free-Float 91,1%
More Financials
Company
Pacific Edge Limited is a cancer diagnostics company. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The Company's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and... 
Sector
Biotechnology & Medical Research
Calendar
07/28 | 11:00pmShareholder meeting
More about the company
Ratings of Pacific Edge Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about PACIFIC EDGE LIMITED
06/20Kaiser Permanente to Commence Use of Second Cxbladder Test
CI
05/30Australia shares track Wall Street higher, bullion shines
RE
05/27Pacific Edge Limited Reports Earnings Results for the Full Year Ended March 3..
CI
04/27Pacific Edge Appoints Andrew Mcintosh as Chief of Information Systems and Dec..
CI
04/11Australian shares fall after abandoning of vaccination targets
RE
04/08Australia shares snap 5-day rally as vaccine rollout suffers setback
RE
03/30Australia shares jump 1% on financials, mining boost
RE
02/25Australia, NZ shares tumble after Wall Street tech rout
RE
2020Australian shares fall as new coronavirus strain spooks market
RE
2020Australia shares make cautious gains ahead of U.S. election outcome
RE
2020Pacific Edge Limited Announces Management Changes
CI
2020PACIFIC EDGE : Diagnostics Notified of CMS LCD Coverage for Cxbladder«
AQ
2020Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder«
GL
2020Pacific Edge Diagnostics Notifies the CMS LCD Coverage for Cxbladder
CI
2020Pacific Edge Limited announced that it expects to receive NZD 22 million in f..
CI
More news
News in other languages on PACIFIC EDGE LIMITED

- No features available -

More news
Chart PACIFIC EDGE LIMITED
Duration : Period :
Pacific Edge Limited Technical Analysis Chart | PEB | NZPEBE0002S1 | MarketScreener
Technical analysis trends PACIFIC EDGE LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,22 NZD
Average target price 1,50 NZD
Spread / Average Target 23,0%
EPS Revisions
Managers and Directors
David Gregory Darling Chief Executive Officer, Executive Director & MD
Grant Gibson Chief Financial Officer
Chris J. Gallaher Chairman
Parry Guilford Chief Scientific Officer
Andrew McIntosh Head-Information Systems & Decision Support
Sector and Competitors
1st jan.Capi. (M$)
PACIFIC EDGE LIMITED0.00%620
MODERNA, INC.214.44%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.35.73%47 396
CELLTRION, INC.-26.60%31 265
SEAGEN INC.-17.54%25 955